Insider Transactions in Q4 2022 at Roivant Sciences Ltd. (ROIV)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
23,761
-2.72%
|
$190,088
$8.0 P/Share
|
|
Dec 23
2022
|
Eric Venker President & COO |
SELL
Other acquisition or disposition
|
Direct |
16,031
-1.75%
|
$112,217
$7.1 P/Share
|
|
Dec 23
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Other acquisition or disposition
|
Direct |
1,592
-1.16%
|
$11,144
$7.1 P/Share
|
|
Dec 23
2022
|
Matthew Gline CEO |
SELL
Other acquisition or disposition
|
Direct |
19,408
-1.7%
|
$135,856
$7.1 P/Share
|
|
Dec 09
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
133,376
-13.05%
|
$933,632
$7.03 P/Share
|
|
Dec 08
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
11,729
-1.13%
|
$82,103
$7.0 P/Share
|
|
Nov 20
2022
|
Eric Venker President & COO |
SELL
Other acquisition or disposition
|
Direct |
16,003
-1.52%
|
$80,015
$5.0 P/Share
|
|
Nov 20
2022
|
Matthew Gline CEO |
SELL
Other acquisition or disposition
|
Direct |
19,373
-1.66%
|
$96,865
$5.0 P/Share
|
|
Nov 20
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Other acquisition or disposition
|
Direct |
1,584
-1.14%
|
$7,920
$5.0 P/Share
|
|
Nov 10
2022
|
Svf Investments (Uk) LTD |
SELL
Open market or private sale
|
Indirect |
4,343,919
-4.37%
|
$17,375,676
$4.75 P/Share
|
|
Nov 10
2022
|
Keith S Manchester |
SELL
Open market or private sale
|
Indirect |
3,922,504
-3.93%
|
$15,690,016
$4.75 P/Share
|
|
Nov 10
2022
|
Daniel Allen Gold |
SELL
Open market or private sale
|
Indirect |
5,656,081
-4.02%
|
$22,624,324
$4.75 P/Share
|
|
Nov 10
2022
|
Daniel Allen Gold |
SELL
Bona fide gift
|
Direct |
750,000
-93.5%
|
-
|
|
Nov 10
2022
|
Qvt Financial LP |
SELL
Open market or private sale
|
Indirect |
5,656,081
-4.02%
|
$22,624,324
$4.75 P/Share
|
|
Nov 10
2022
|
Dexcel Pharma Technologies Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,000,000
+3.74%
|
$20,000,000
$5.0 P/Share
|
|
Nov 09
2022
|
Keith S Manchester |
SELL
Other acquisition or disposition
|
Indirect |
1,196,200
-3.01%
|
-
|
|
Nov 09
2022
|
Daniel Allen Gold |
SELL
Other acquisition or disposition
|
Indirect |
1,196,200
-3.01%
|
-
|
|
Nov 09
2022
|
Qvt Financial LP |
SELL
Other acquisition or disposition
|
Indirect |
1,196,200
-3.01%
|
-
|
|
Oct 31
2022
|
James C Momtazee |
BUY
Grant, award, or other acquisition
|
Direct |
3,404
+5.61%
|
-
|
|
Oct 31
2022
|
Ilan Oren |
BUY
Grant, award, or other acquisition
|
Direct |
2,796
+4.59%
|
-
|
|
Oct 25
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
15,922
-1.49%
|
$63,688
$4.4 P/Share
|
|
Oct 25
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,588
-1.13%
|
$6,352
$4.4 P/Share
|
|
Oct 25
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
19,276
-1.63%
|
$77,104
$4.4 P/Share
|
|
Oct 16
2022
|
James C Momtazee |
BUY
Grant, award, or other acquisition
|
Direct |
1,594
+2.07%
|
-
|